title: Potentiated anti-inflammatory effect of combined 780 nm and 660 nm low level laser therapy on the experimental laryngitis.
abstract: Reflux laryngitis is a common clinic complication of nasogastric intubation (NSGI). Since there is no report concerning the effects of low level laser therapy (LLLT) on reflux laryngitis, this study aimed to analyze the protective effect of single and combined therapies with low level laser at the doses of 2.1J and 2.1+1.2 J with a total irradiation time of 30s and 30+30 s, respectively, on a model of neurogenic reflux laryngitis. NSGI was performed in Wistar rats, assigned into groups: NGI (no treatment), NLT17.5 (single therapy), and NLT17.5/10.0 (combined therapy, applied sequentially). Additional non-intubated and non-irradiated rats were use as controls (CTR). Myeloperoxidase (MPO) activity was assessed by colorimetric method after the intubation period (on days 1, 3, 5, and 7), whereas paraffin-embedded laryngeal specimens were used to carry out histopathological analysis of the inflammatory response, granulation tissue, and collagen deposition 7 days after NSGI. Significant reduction in MPO activity (p<0.05) and in the severity of the inflammatory response (p<0.05), and improvement in the granulation tissue (p<0.05) was observed in NLT17.5/10.0 group. Mast cells count was significantly decreased in NGI and NLT17.5 groups (p<0.001), whereas no difference was observed between NLT17.5/10.0 and CTR groups (p>0.05). NLT17.5/10.0 group also showed better collagenization pattern, in comparison to NGI and NLT17.5 groups. This study suggests that the combined therapy successfully modulated the inflammatory response and collagenization in experimental model of NSGI-induced neurogenic laryngitis.
authors.affiliation: Departamento de Fisiologia, Universidade Federal de Sergipe, Av. Marechal Rondon, São Cristóvão, Sergipe, Brazil.
authors.forename: Renata R
authors.initials: RR
authors.lastname: Marinho
authors.forename: Renata M
authors.initials: RM
authors.lastname: Matos
authors.forename: Jandson S
authors.initials: JS
authors.lastname: Santos
authors.forename: Maria A G
authors.initials: MA
authors.lastname: Ribeiro
authors.forename: Salete
authors.initials: S
authors.lastname: Smaniotto
authors.forename: Emiliano O
authors.initials: EO
authors.lastname: Barreto
authors.forename: Ronaldo A
authors.initials: RA
authors.lastname: Ribeiro
authors.forename: Roberto C P
authors.initials: RC
authors.lastname: Lima
authors.forename: Ricardo L C
authors.initials: RL
authors.lastname: Albuquerque
authors.forename: Sara M
authors.initials: SM
authors.lastname: Thomazzi
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D002452:Cell Count; D004195:Disease Models, Animal; D007827:Laryngitis / Q000201:enzymology / Q000276:immunology / Q000628:therapy*; D007830:Larynx / Q000473:pathology; D028022:Low-Level Light Therapy; D008297:Male; D008407:Mast Cells / Q000166:cytology / Q000201:enzymology / Q000276:immunology; D009195:Peroxidase / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar
chemical_list: D000893:Anti-Inflammatory Agents; D009195:Peroxidase